Market revenue in 2020 | USD 97.1 billion |
Market revenue in 2028 | USD 355.3 billion |
Growth rate | 17.6% (CAGR from 2020 to 2028) |
Largest segment | Detection kits |
Fastest growing segment | Detection Kits |
Historical data covered | 2018 - 2019 |
Base year for estimation | 2020 |
Forecast period covered | 2021 - 2028 |
Quantitative units | Revenue in USD billion |
Market segmentation | Purification Kits, Amplification Kits, Detection Kits, Isolation Kits |
Key market players worldwide | Thermo Fisher Scientific Inc, Qiagen NV, New England Biolabs, Illumina Inc, Agilent Technologies Inc, Bio-Rad Laboratories Inc, Merck KGaA, Promega, Takara Bio Inc, LGC Group, Toyobo Co Ltd |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biotechnology reagents & kits market will help companies and investors design strategic landscapes.
Detection kits was the largest segment with a revenue share of 22.76% in 2020. Horizon Databook has segmented the Asia Pacific biotechnology reagents & kits market based on purification kits, amplification kits, detection kits, isolation kits covering the revenue growth of each sub-segment from 2018 to 2028.
Asia Pacific is a lucrative market for biotechnology reagents and kits, with growing disposable income, improving diagnostics & therapeutic infrastructure, and increasing research activities for development of effective therapeutics. Around 60% of the world’s population resides in Asia, which represents the high untapped opportunities.
In addition, there is growing incidence and prevalence of diseases due to lifestyle changes. Improving health care infrastructure, entry of large biotechnological organizations, and increasing R&D activities are also expected to contribute to growth of the market.
This strategic alliance is focused on building a global standard for plasmid and virus manufacturing in China. Under this collaboration, Merck planned to give comprehensive products, services, and training to Genscript for manufacturing.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific biotechnology reagents & kits market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific biotechnology reagents & kits market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account